Drug Profile
Desmetramadol - Syntrix Biosystems
Alternative Names: O-demethyl-tramadol; O-desmethyl-tramadol; O-DSMT; ODMT; OmnitramLatest Information Update: 05 Mar 2021
Price :
$50
*
At a glance
- Originator Syntrix Biosystems
- Class Cyclohexanols; Dimethylamines; Opioid analgesics; Phenyl ethers; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Pain
Most Recent Events
- 05 Mar 2021 Phase-II development is ongoing in USA (PO)
- 18 Jan 2021 Syntrix Biosystems completes a phase I trial for Pain (In volunteers) in USA (PO) (NCT04683926)
- 08 Jan 2021 Syntrix Biosystems initiates a phase I trial for Pain (In volunteers) in USA (PO) (NCT04683926)